Abstract
Objective
To evaluate the efficacy of Chinese plaster containing rhubarb and mirabilite on surgical site infection (SSI) in patients with cesarean delivery (CD) by performing a randomized controlled trial.
Methods
This randomized controlled trial included 560 patients with CD due to fetal head descent enrolled at a tertiary teaching center between December 31, 2018 and October 31, 2021. Eligible patients were randomly assigned to a Chinese medicine (CM) group (280 cases) or a placebo group (280 cases) by a random number table, and were treated with CM plaster (made by rhubarb and mirabilite) or a placebo plaster, respectively. Both courses of treatment lasted from the day 1 of CD, followed day 2 until discharge. The primary outcome was the total number of patients with superficial, deep and organ/space SSI. The secondary outcome was duration of postoperative hospital stay, antibiotic intake, and unplanned readmission or reoperation due to SSI. All reported efficacy and safety outcomes were confirmed by a central adjudication committee that was unaware of the study-group assignments.
Results
During the recovery process after CD, the rates of localized swelling, redness and heat were significantly lower in the CM group than in the placebo group [7.55% (20/265) vs. 17.21% (47/274), P<0.01]. The durution of postoperative antibiotic intake was shorter in the CM group than in the placebo group (P<0.01). The duration of postoperative hospital stay was significantly shorter in the CM group than in the placebo group (5.49 ± 2.68 days vs. 8.96 ± 2.35 days, P<0.01). The rate of postoperative C-reactive protein elevation (≽100 mg/L) was lower in the CM group than in the placebo group [27.6% (73/265) vs. 43.8% (120/274), P<0.01]. However, there was no difference in purulent drainage rate from incision and superficial opening of incision between the two groups. No intestinal reactions and skin allergies were found in the CM group.
Conclusions
CM plaster containing rhubarb and mirabilite had an effect on SSI. It is safe for mothers and imposes lower economic and mental burdens on patients undergoing CD. (Registration No. ChiCTR2100054626)
Similar content being viewed by others
References
Centers for Disease Control and Prevention’s National Healthcare Safety Network Classification for Surgical Site Infection (SSI). Adapted from centers for disease control and prevention’s national healthcare safety network classification for surgical site infection (SSI). Available at http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf.
Shea SK, Soper DE. Prevention of cesarean delivery surgical site infections. Obstet Gynecol Surv 2019;74:99–110.
Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection. JAMA Surg 2017;152:784–791.
Joseph LF, Tita TN. Prevention and management of cesarean wound infection. Obstetrics Gynecol Clin North Am 2014;41:671–689.
Liu SW, Guo J, Wu WK, Chen ZL, Zhang N. Treatment of uncomplicated recurrent urinary tract infection with Chinese medicine formula: a randomized controlled trial. Chin J Integr Med 2019;25:16–22.
Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet (London, England) 2008; 372:1938–1940.
Ma Y, Zhou KH, Fan J, Sun SC. Traditional Chinese medicine: potential approaches from modern dynamical complexity theories. Front Med 2016;10:28–32.
Zhuang TX, Gu XY, Zhou N, Ding LL, Yang L, Zhou MM. Hepatoprotection and hepatotoxicity of Chinese herb Rhubarb (Dahuang): how to properly control the “General (Jiang Jun)” in Chinese medical herb. Biomed Pharmacother 2020;127:110224.
Serhat K, Fatma K, Mustafa K, Omer K, Suat T, Ismail T, et al. Bioactive contents, in vitro antiradical, antimicrobial and cytotoxic properties of rhubarb (Rheum ribes L.) extracts. Nat Prod Res 2020;34:353–3357.
Wang Y, Huang X, Liang QH, Mao XL, Liu ZQ, Zhou HH, et al. A strategy for detecting absorbed bioactive compounds for quality control in the water extract of rhubarb by ultra performance liquid chromatography with photodiode array detector. Chin J Integr Med 2012; 18:690–698.
Sneha C, Soniya G, Lesley RV, Vinod Kr, Anil KS, Vikas B. Probing gallic acid for its broad spectrum applications. Mini Rev Med Chem 2018;18:1283–1293.
Lu YY, Hao CY, He WB, Tang C, Shao ZY. Experimental research on preventing mechanical phlebitis arising from indwelling needles in intravenous therapy by external application of mirabilite. Expe Ther Med 2018;15:276–282.
Fan TT, Cheng BL, Fang XM, Chen YC, Su F. Application of Chinese medicine in the management of critical conditions: a review on sepsis. Am J Chin Med 2020;48:1315–1330.
American College of Obstetricians and Gynecologists. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006;108:1039–1047.
Cobelens STM, van DBK, van PMG. INFEXIT: implementing vaginal disinfection prior to cesarean section. Eur J Obstet Gynecol Reprod Biol 2022;279:55–59.
Gulishaera T, Niu XL, Naerbuli. Warm needling combined with external application of mirabilite for 27 cases of early fat liquefaction after gynecological operation. Chin Acup Moxibus (Chin) 2015;35:1125–1126.
Zhong Y, Zheng C, Du WX, Zheng JH, Xu SC, Tong PJ. Mirabilite with ice pack after total knee arthroplasty: a randomized controlled trial study. Evid Based Complement Alternat Med 2021; 2021:6611614.
Tomioka H. Usefulness of chinese herbal medicines as host-directed therapeutics against mycobacterial infections: a review. Am J Chin Med 2017;45:1597–1611.
Li L, Wang L, Fan WX, Jiang Y, Zhang C, Li JH, et al. The application of fermentation technology in traditional Chinese medicine: a review. Am J Chin Med 2020;48:899–921.
Cui YL, Zhang S, Tian ZT, Lin ZF, Chen DC. Rhubarb antagonizes matrix metalloproteinase-9-induced vascular endothelial permeability. Chin Med J (Engl) 2016;129:1737–1743.
Cao YJ, Pu ZJ, Tang YP, Shen J, Chen YY, Kang A, et al. Advances in bio-active constituents, pharmacology and clinical applications of rhubarb. Chin Med 2017;12:36–48.
Piret R, Julia K, Dea A, Kadrin M, Karmen K, Peeter L, et al. Antibacterial and antioxidative properties of different parts of garden rhubarb, blackcurrant, chokeberry and blue honeysuckle. J Sci Food Agric 2019;99:2311–2320.
Ayşenur A, Fulya G, Mehmet SN, Mehmet HA, Mehmet HÇ, Buket U, et al. Biological synthesis of silver nanoparticles using Rheum ribes and evaluation of their anticarcinogenic and antimicrobial potential: a novel approach in phytonanotechnology. J Pharm Biomed Anal 2020;179:113012.
Monika SG. The Health benefits of emodin, a natural anthraquinone derived from rhubarb—a summary update. Int J Mol Sci 2021;22:9522.
Wang CC, Li L, Lau CB, Leung PC, Fung KP. Pregnancy outcomes, embryonic and fetal development in maternal exposure to Chinese medicines. Birth Defects Res 2013;99:275–291.
Jun P, Rahmat E, Han CH, Yang C, Kang Y. Traditional Chinese medicine and traditional indonesian medicine: a comparative review of herbal medicines restricted in pregnancy. Chin J Integr Med 2021;27:794–800.
Tuuli MG, Liu L, Longman RE, Odibo AO, Macones GA, Cahill AG. Infectious morbidity is higher after second-stage compared with first-stage cesareans. Am J Obstet Gynecol 2014;211:e1–e6.
Acknowledgments
We thank those who have devoted much to this study, including nurses, study doctors, statisticians, reviewers, and editors, especially Dr. HU Min. They were not financially compensated for their contributions.
Author information
Authors and Affiliations
Contributions
Han GY: data collection, manuscript writing; Li DM and Wu XL: data collection and data analysis; He XB: project development and manuscript editing. All the authors reviewed and approved the final version of the manuscript for publication.
Corresponding author
Additional information
Conflict of Interest
The authors declare no conflicts of interest.
Supported by the Natural Science Foundation of Ningbo, China (No. 2019A610312) and the Project of Ningbo Leading Medical & Health Discipline, China (No. 2010-S04)
Rights and permissions
About this article
Cite this article
Han, Gy., Wu, Xl., Li, Dm. et al. Chinese Medicine Plaster as A New Treatment for Surgical Site Infection in Patients with Cesarean Delivery: A Randomized, Double-Blind, Controlled Trial. Chin. J. Integr. Med. 29, 483–489 (2023). https://doi.org/10.1007/s11655-023-3730-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-023-3730-0